Innovation: early diagnosis in community settings
This report focuses on early diagnosis of heart failure in community settings, identifying four key areas of innovation.
Find out more
From guidelines to action
This project aims to help the heart failure community advocate for change to close the gap between clinical guidelines and the reality of care for people living with heart failure.
Find out more
Spotlight series
The Spotlight series features evidence-based reports on topics at the forefront of debates about the future of heart failure care.
Find out more
heart graphic

Helping advance meaningful policy change on heart failure

The Heart Failure Policy Network is an independent, multidisciplinary platform of healthcare professionals, advocacy groups and policymakers from across Europe.

We aim to raise awareness of the unmet needs surrounding heart failure and its care, and to help drive meaningful changes in policy and practice.

Find out more
Latest
9 things we learnt from the Heart Failure Policy Summit 2022
13 January 2023

Last year’s Summit brought together experts from the heart failure and wider health advocacy communities. Here, we reflect on some learning points.

Read article
Latest
Innovation in heart failure: how can we ensure early diagnosis?
8 December 2022

Our ‘Innovation in heart failure: early diagnosis in community settings’ report outlines the urgent need to boost timely diagnosis and presents a variety of promising initiatives.

Read article
Latest
It is time to put quality of life at the centre of heart failure care
15 November 2022

More than 90% of people with heart failure would like regular discussion about quality of life to be part of their care, but this only happens for 20%.

Read article
heart failure graphic
What is heart failure?

Affecting at least 15 million adults in Europe, heart failure is a common but complex clinical syndrome that occurs when the heart is unable to pump enough blood to meet body’s needs.

Its prevalence is expected to rise due to population ageing and improved survival rates for other long-term conditions, including cardiovascular diseases.

Find out more
The Heart Failure Policy Network is an independent, multidisciplinary platform made possible with financial support from AstraZeneca, CSL Vifor, Boehringer Ingelheim and Roche Diagnostics. The content produced by the Network is not biased toward any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members. All members provide their time for free. The Network is hosted by The Health Policy Partnership .